Companies /Healthcare
Kymera Therapeutics Inc
NASDAQ: KYMR Biotechnology
$131.73
▲ $3.61 (+2.82%) today
Markets closed · 9:19am ET

Kymera Therapeutics (KYMR) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
43%
EPS beat rate
−3.43%
Avg. EPS surprise
Consecutive EPS misses
KYMR vs Market · 30-day return after each reportKYMRS&P 500
0%+30%+60%+60.9%+6.6%Q1 25+22.6%+3.4%Q2 25+11.2%+1.6%Q3 25−16.4%−8.3%Q4 25−12.1%+5.7%Q1 26+11.3%+0.1%Q2 26
0%+30%+60%Q1 25Q3 25Q1 26
KYMR EPS Trend · estimate vs actualEstimateActual
$-1.20$-0.80$-0.40$0.00$-0.91$-0.82Q1 25$-0.80$-0.95Q2 25$-0.79$-0.94Q3 25$-0.79$-0.97Q4 25$-0.85$-0.71Q1 26$-0.74$-0.62Q2 26$-1.27$-1.32Q3 26
$-1.20$-0.80$-0.40$0.00Q1 25Q3 25Q1 26Q3 26
KYMR Revenue Trend · estimate vs actualEstimateActual
$0$20.0M$40.0M$60.0M$10.7M$22.1MQ1 25$24.2M$11.5MQ2 25$23.1M$2.8MQ3 25$14.8M$2.9MQ4 25$8.2M$34.4MQ1 26$32.8M$65.0MQ2 26
$0$20.0M$40.0M$60.0MQ1 25Q3 25Q1 26

How Often Does Kymera Therapeutics Beat Earnings Estimates?

Kymera Therapeutics beat EPS estimates in 3 of its last 7 reported quarters.

KYMR quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 $-1.32 est. $-1.27 −4.22% — —
Q2 2026 $-0.62 est. $-0.74 +15.98% $65.0M est. $32.8M +98.32%
Q1 2026 $-0.71 est. $-0.85 +16.07% $34.4M est. $8.2M +317.57%
Q4 2025 $-0.97 est. $-0.79 −23.10% $2.9M est. $14.8M −80.61%
Q3 2025 $-0.94 est. $-0.79 −19.50% $2.8M est. $23.1M −88.06%
Q2 2025 $-0.95 est. $-0.80 −19.12% $11.5M est. $24.2M −52.51%
Q1 2025 $-0.82 est. $-0.91 +9.90% $22.1M est. $10.7M +105.88%

Figures from SEC filings and company reports. Not investment advice.